Publication | Closed Access

Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study

Neuro-oncologyRecurrent Malignant GliomaMedicineIntracranial PressureBrain InjuryNeurologyHigh-grade GliomasNeuroscienceCerebral Blood FlowBrain LesionOncologyGliomaCerebral Vascular Regulation